Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).

Epilepsia open·2025
Same author

Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX).

Scientific reports·2025
Same author

Retraction notice to "Neurological outcome of post-anoxic refractory status epilepticus after aggressive treatment" [Epilepsy Behav. 101 (2019) 106374].

Epilepsy & behavior : E&B·2024
Same author

Risk factors for attempted suicide in non-psychotic patients with suicidal ideation.

Rivista di psichiatria·2024
Same author

Prevalence of epilepsy in childhood: An epidemiological study in Sardinia.

Epilepsy & behavior : E&B·2023
Same author

Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions.

Journal of neurology·2023

Related Experiment Video

Updated: Jun 5, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Treating epilepsy across its different stages.

Ettore Beghi1

  • 1Laboratory of Neurological Disorders, Istituto Mario Negri, Milan, Italy.

Therapeutic Advances in Neurological Disorders
|December 24, 2010
PubMed
Summary
This summary is machine-generated.

Epilepsy treatment with antiepileptic drugs (AEDs) is symptomatic and has limitations. Personalized treatment selection and dose optimization are crucial for managing seizures effectively and safely.

Keywords:
acute symptomatic seizuresantiepileptic drugsepilepsytreatment discontinuation

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Related Experiment Videos

Last Updated: Jun 5, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Medicine

Background:

  • Epilepsy requires long-term treatment with antiepileptic drugs (AEDs).
  • Current AEDs suppress seizures but do not cure the condition and have tolerability and teratogenic limitations.
  • Second-generation AEDs offer similar efficacy to older drugs with potentially better tolerability.

Purpose of the Study:

  • To review the current landscape of epilepsy treatment, focusing on symptomatic management and drug limitations.
  • To provide guidance on the appropriate use of AEDs for different seizure types and patient populations.
  • To emphasize the importance of individualized treatment strategies, including dose optimization and drug selection based on safety and efficacy.

Main Methods:

  • Review of existing literature and clinical trial data (Class I and pragmatic trials) on antiepileptic drugs.
  • Analysis of treatment guidelines for acute symptomatic seizures, first unprovoked seizures, and established epilepsy.
  • Consideration of patient-specific factors such as age, seizure type, comorbidities, and psychosocial profile.

Main Results:

  • Drug therapy for epilepsy is primarily symptomatic, aiming to suppress seizures.
  • Specific AEDs are recommended for partial seizures in different age groups: oxcarbazepine (children), carbamazepine or lamotrigine (adults), lamotrigine or gabapentin (elderly).
  • Valproate is supported for generalized seizures, with caution for women of childbearing age.
  • Treatment individualization, dose optimization, and consideration of drug safety profiles are essential, especially when switching therapies.

Conclusions:

  • Epilepsy management necessitates a personalized approach, balancing efficacy, tolerability, and safety.
  • Treatment decisions should consider the specific epilepsy syndrome, patient characteristics, and psychosocial factors.
  • Discontinuation of AEDs should be carefully considered after long-term seizure remission.